https://scholars.lib.ntu.edu.tw/handle/123456789/468859
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Tung K.-H. | en_US |
dc.contributor.author | CHUNG-WU LIN | en_US |
dc.contributor.author | Kuo C.-C. | en_US |
dc.contributor.author | Li L.-T. | en_US |
dc.contributor.author | Kuo Y.-H. | en_US |
dc.contributor.author | Wu H.-C. | en_US |
dc.creator | Wu H.-C.;CHUNG-WU LIN;Kuo Y.-H.;Li L.-T.;Kuo C.-C.;CHUNG-WU LIN;Tung K.-H. | - |
dc.date.accessioned | 2020-03-03T03:36:44Z | - |
dc.date.available | 2020-03-03T03:36:44Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873522077&doi=10.1016%2fj.canlet.2012.12.001&partnerID=40&md5=e5eeb838ee5900cba7a631d5de71124a | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/468859 | - |
dc.description.abstract | Pancreatic adenocarcinoma is an aggressive disease with a high mortality rate. In this study, we have newly generated a monoclonal antibody (mAb), Pa65-2, which specifically binds to pancreatic cancer cells and tumor blood vessels. The target protein of Pa65-2 is identified as human clathrin heavy chain (CHC). In vitro and In vivo study showed that suppression of CHC either by shRNA or by Pa65-2 inhibited tumor growth and angiogenesis. One of the key functions of CHC was to bind with the hypoxia-inducing factor (HIF)-1α protein, increasing the stability of this protein and facilitating its nuclear translocation, thereby regulating the expression of VEGF. Taken together, our findings indicate that CHC plays a role in the processes of tumorigenesis and angiogenesis. Pa65-2 antibody or CHC shRNA can potentially be used for pancreatic cancer therapy. ? 2012 Elsevier Ireland Ltd. | - |
dc.relation.ispartof | Cancer Letters | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | clathrin heavy chain; gemcitabine; hypoxia inducible factor 1alpha; immunoglobulin G; monoclonal antibody; monoclonal antibody Pa65 2; short hairpin RNA; unclassified drug; vasculotropin; animal cell; animal experiment; animal model; animal tissue; antineoplastic activity; article; cancer growth; cancer inhibition; cancer therapy; carcinogenesis; controlled study; drug efficacy; drug protein binding; enzyme repression; human; human cell; human tissue; in vitro study; in vivo study; mouse; nonhuman; pancreas adenocarcinoma; pancreas cancer; priority journal; protein expression; protein function; protein protein interaction; protein stability; protein synthesis regulation; protein targeting; protein transport; signal transduction; Adenocarcinoma; Animals; Anoxia; Antibodies, Monoclonal; Apoptosis; Blotting, Western; Cell Cycle Proteins; Cell Proliferation; Chromatin Immunoprecipitation; Electrophoretic Mobility Shift Assay; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Guanine Nucleotide Exchange Factors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Immunoprecipitation; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Neovascularization, Pathologic; Nuclear Proteins; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | - |
dc.title | CHC promotes tumor growth and angiogenesis through regulation of HIF-1α and VEGF signaling | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.canlet.2012.12.001 | - |
dc.identifier.pmid | 23228632 | - |
dc.identifier.scopus | 2-s2.0-84873522077 | - |
dc.relation.pages | 58-67 | - |
dc.relation.journalvolume | 331 | - |
dc.relation.journalissue | 1 | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Pathology | - |
crisitem.author.orcid | 0000-0001-5042-0503 | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。